EC approves Revolade for ITP

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) said the European Commission approved an MAA from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for Revolade ( Promacta - U.S.) eltrombopag to treat thrombocytopeni...